Starling Oncology, Inc. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
Starling Oncology, Inc. (DFPH) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of $6.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2026-03-12
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-12-31 was $12.00K.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-09-30 was $0.00.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-06-30 was -$6.00K.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2025-03-31 was -$6.00K.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2025 was $6.00K, a 95.49% decline from fiscal 2024.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was $133.00K, a 46.59% decline from fiscal 2023.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $249.00K.
- Starling Oncology, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was -$378.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $12.00K derived: sum of 2 quarters · filed 2026-03-12 | $6.00K derived: sum of 3 quarters · filed 2026-03-12 | $6.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | -$6.00K derived: sum of 2 quarters · filed 2025-11-13 | -$6.00K 10-Q · filed 2025-11-13 | -$13.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$6.00K 10-Q · filed 2025-08-13 | -$6.00K 10-Q · filed 2025-08-13 | -$13.00K derived: sum of 3 quarters · filed 2025-08-13 | -$65.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2025-03-31 | -$6.00K 10-Q · filed 2025-05-14 | -$7.00K derived: sum of 2 quarters · filed 2025-05-14 | -$59.00K derived: sum of 3 quarters · filed 2025-05-14 | -$93.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2024-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | -$53.00K derived: sum of 2 quarters · filed 2025-03-26 | -$87.00K derived: sum of 3 quarters · filed 2025-03-26 | $133.00K 10-K · filed 2025-03-26 |
| 2024-09-30 | -$52.00K 10-Q · filed 2024-11-13 | -$86.00K derived: sum of 2 quarters · filed 2024-11-13 | $134.00K 10-Q · filed 2024-11-13 | $126.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | -$34.00K 10-Q · filed 2024-08-13 | -$115.00K derived: sum of 2 quarters · filed 2024-08-13 | $178.00K derived: sum of 3 quarters · filed 2024-08-13 | $21.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | -$81.00K 10-Q · filed 2024-05-14 | $212.00K derived: sum of 2 quarters · filed 2024-05-14 | $55.00K derived: sum of 3 quarters · filed 2024-05-14 | -$201.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $293.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $136.00K derived: sum of 2 quarters · filed 2024-03-28 | -$120.00K derived: sum of 3 quarters · filed 2024-03-28 | $249.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | -$157.00K 10-Q · filed 2023-11-08 | -$413.00K derived: sum of 2 quarters · filed 2023-11-08 | -$44.00K 10-Q · filed 2023-11-08 | -$872.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | -$256.00K 10-Q · filed 2023-08-09 | -$113.00K 10-Q · filed 2023-08-09 | -$715.00K derived: sum of 3 quarters · filed 2023-08-09 | -$777.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | -$143.00K 10-Q · filed 2023-05-10 | -$459.00K derived: sum of 2 quarters · filed 2023-05-10 | -$521.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2022-12-31 | -$316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$378.00K derived: sum of 2 quarters · filed 2023-03-16 | -$378.00K 10-K · filed 2023-03-16 | |
| 2022-09-30 | -$62.00K 10-Q · filed 2022-11-09 | -$62.00K 10-Q · filed 2022-11-09 |